Application of statistical process control to qualitative molecular diagnostic assays

Por O'Brien, Cathal P., Finn, Stephen P.
Publicado no Front Mol Biosci (2014)

Chronic activation of extracellular-signal-regulated protein kinases by phenylephrine is required to elicit a hypertrophic response in cardiac myocytes.

Por Barron, Anthony J, Finn, Stephen G, Fuller, Stephen J
Publicado em 2003

PROSTATE CANCER: Re-focusing on Androgen Receptor Signaling

Por Nieto, Maria, Finn, Stephen, Loda, Massimo, Hahn, William C.
Publicado em 2007

Enzalutamide for treatment of CRPC: Rationale for sequencing and potential clinical biomarker for resistance

Por Lochrin, Sarah E, Figg, William D, Finn, Stephen P
Publicado no Cancer Biol Ther (2015)

Systems-Level Modeling of Cancer-Fibroblast Interaction

Por Wadlow, Raymond C., Wittner, Ben S., Finley, S. Aidan, Bergquist, Henry, Upadhyay, Rabi, Finn, Stephen, Loda, Massimo, Mahmood, Umar, Ramaswamy, Sridhar
Publicado em 2009

Insights into the regulation of eukaryotic elongation factor 2 kinase and the interplay between its domains

Por Pigott, Craig R., Mikolajek, Halina, Moore, Claire E., Finn, Stephen J., Phippen, Curtis W., Werner, Jörn M., Proud, Christopher G.
Publicado em 2012

Golgi phosphoprotein 2 (GOLPH2) is a novel bile acid-responsive modulator of oesophageal cell migration and invasion

Por Byrne, Anne-Marie, Bekiaris, Spiros, Duggan, Gina, Prichard, David, Kirca, Murat, Finn, Stephen, Reynolds, John V, Kelleher, Dermot, Long, Aideen
Publicado no Br J Cancer (2015)

Exercise rapidly increases eukaryotic elongation factor 2 phosphorylation in skeletal muscle of men

Por Rose, Adam J, Broholm, Christa, Kiillerich, Kristian, Finn, Stephen G, Proud, Christopher G, Rider, Mark H, Richter, Erik A, Kiens, Bente
Publicado em 2005

Strategic targeting of the PI3K–NFκB axis in cisplatin-resistant NSCLC

Por Heavey, Susan, Godwin, Peter, Baird, Anne-Marie, Barr, Martin P, Umezawa, Kazuo, Cuffe, Sinéad, Finn, Stephen P, O’Byrne, Kenneth J, Gately, Kathy
Publicado em 2014

Tumor expression of adiponectin receptor 2 and lethal prostate cancer

Por Rider, Jennifer R., Fiorentino, Michelangelo, Kelly, Rachel, Gerke, Travis, Jordahl, Kristina, Sinnott, Jennifer A., Giovannucci, Edward L., Loda, Massimo, Mucci, Lorelei A., Finn, Stephen
Publicado no Carcinogenesis (2015)

Utility of multispectral imaging in automated quantitative scoring of immunohistochemistry

Por Fiore, Christopher, Bailey, Dyane, Conlon, Niamh, Wu, Xiaoqiu, Martin, Neil, Fiorentino, Michelangelo, Finn, Stephen, Fall, Katja, Andersson, Swen-Olof, Andren, Ove, Loda, Massimo, Flavin, Richard
Publicado em 2012

Calcium-Sensing Receptor Tumor Expression and Lethal Prostate Cancer Progression

Por Ahearn, Thomas U., Tchrakian, Nairi, Wilson, Kathryn M., Lis, Rosina, Nuttall, Elizabeth, Sesso, Howard D., Loda, Massimo, Giovannucci, Edward, Mucci, Lorelei A., Finn, Stephen, Shui, Irene M.
Publicado no J Clin Endocrinol Metab (2016)

Effect of ret/PTC 1 rearrangement on transcription and post-transcriptional regulation in a papillary thyroid carcinoma model

Por Cahill, Susanne, Smyth, Paul, Finn, Stephen P, Denning, Karen, Flavin, Richard, O'Regan, Esther M, Li, Jinghuan, Potratz, Astrid, Guenther, Simone M, Henfrey, Richard, O'Leary, John J, Sheils, Orla
Publicado em 2006

Gleason Grade Progression Is Uncommon

Por Penney, Kathryn L., Stampfer, Meir J., Jahn, Jaquelyn L, Sinnott, Jennifer A., Flavin, Richard, Rider, Jennifer R., Finn, Stephen, Giovannucci, Edward, Sesso, Howard D., Loda, Massimo, Mucci, Lorelei A., Fiorentino, Michelangelo
Publicado em 2013

Gleason Score and Lethal Prostate Cancer: Does 3 + 4 = 4 + 3?

Por Stark, Jennifer R., Perner, Sven, Stampfer, Meir J., Sinnott, Jennifer A., Finn, Stephen, Eisenstein, Anna S., Ma, Jing, Fiorentino, Michelangelo, Kurth, Tobias, Loda, Massimo, Giovannucci, Edward L., Rubin, Mark A., Mucci, Lorelei A.
Publicado em 2009

Prostate-specific membrane antigen protein expression in tumor tissue and risk of lethal prostate cancer

Por Kasperzyk, Julie L., Finn, Stephen P., Flavin, Richard, Fiorentino, Michelangelo, Lis, Rosina, Hendrickson, Whitney K., Clinton, Steven K., Sesso, Howard D., Giovannucci, Edward L., Stampfer, Meir J., Loda, Massimo, Mucci, Lorelei A.
Publicado em 2013

Common polymorphisms in the adiponectin and its receptor genes, adiponectin levels and the risk of prostate cancer

Por Dhillon, Preet K., Penney, Kathryn L., Schumacher, Fredrick, Rider, Jennifer R., Sesso, Howard D., Pollak, Michael, Fiorentino, Michelangelo, Finn, Stephen, Loda, Massimo, Rifai, Nader, Mucci, Lorelei A., Giovannucci, Edward, Stampfer, Meir J., Ma, Jing
Publicado em 2011

Semiautomated Multiplexed Quantum Dot-Based in Situ Hybridization and Spectral Deconvolution

Por Byers, Richard J., Di Vizio, Dolores, O’Connell, Fionnuala, Tholouli, Eleni, Levenson, Richard M., Gossard, Kirk, Twomey, David, Yang, Yu, Benedettini, Elisa, Rose, Joshua, Ligon, Keith L., Finn, Stephen P., Golub, Todd R., Loda, Massimo
Publicado em 2007

Potential role of miR-9 and miR-223 in recurrent ovarian cancer

Por Laios, Alexandros, O'Toole, Sharon, Flavin, Richard, Martin, Cara, Kelly, Lynn, Ring, Martina, Finn, Stephen P, Barrett, Ciara, Loda, Massimo, Gleeson, Noreen, D'Arcy, Tom, McGuinness, Eamonn, Sheils, Orla, Sheppard, Brian, O' Leary, John
Publicado em 2008

Measuring PI3K Activation: Clinicopathologic, Immunohistochemical, and RNA Expression Analysis in Prostate Cancer

Por Martin, Neil E, Gerke, Travis, Sinnott, Jennifer A, Stack, Edward C, Andrén, Ove, Andersson, Swen-Olof, Johansson, Jan-Erik, Fiorentino, Michelangelo, Finn, Stephen, Fedele, Giuseppe, Stampfer, Meir, Kantoff, Philip W, Mucci, Lorelei A, Loda, Massimo
Publicado no Mol Cancer Res (2015)